WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience Introducing ALZET?ew Model 2006 Pump
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (86)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Radford, K. M.
Right arrow Articles by Kawashima, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Radford, K. M.
Right arrow Articles by Kawashima, E.

 Previous Article  |  Next Article 

Volume 17, Number 17, Issue of September 1, 1997 pp. 6529-6533
Copyright ©1997 Society for Neuroscience

Baculovirus Expression Provides Direct Evidence for Heteromeric Assembly of P2X2 and P2X3 Receptors

Kathryn M. Radford, Caterina Virginio, Annmarie Surprenant, R. Alan North, and Eric Kawashima

Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development, 1228 Geneva, Switzerland

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES


ABSTRACT

P2X2 and P2X3 are subunits of P2X receptors, cation channels opened by binding extracellular ATP. cDNAs encoding P2X2 and P2X3 receptor subunits, each with one of two C-terminal epitope tags, were cloned into baculovirus. Virally infected insect cells (Spodoptera frugiperda) expressed moderate to high levels of the corresponding proteins, as detected by Western blotting, by the specific binding of [35S]ATP and by whole-cell recordings of membrane current evoked by ATP or alpha beta methylene-ATP. In cells infected at the same time with two viruses encoding P2X2 and P2X3 receptors, the two proteins could be cross-immunoprecipitated with antibodies specific for either of the epitope tags. Whole-cell recordings from these cells showed that ATP and alpha beta methylene-ATP evoked currents with agonist sensitivity and desensitization quite distinct from those observed when P2X2 or P2X3 receptors were expressed alone. The results offer a method to express large amounts of P2X receptor protein, and they provide direct evidence that P2X2 and P2X3 subunits assemble to form heteromeric channels having distinct properties from those formed as homomers.

Key words: ATP; P2X receptors; baculovirus; cation channels; coimmunoprecipitation; subunit assembly


INTRODUCTION

P2X receptors are membrane ion channels activated by extracellular ATP. Currently, seven subunits are known (P2X1-P2X7); each of these can form channels when expressed from the corresponding cDNA in cells such as Xenopus oocytes or human embryonic kidney (HEK) cells, although P2X5 and P2X6 do so only poorly (Collo et al., 1996; North, 1996). It is assumed that, when heterologously expressed singly, these subunits assemble into channels as homo-oligomers. On the other hand, two lines of evidence suggest that, as for ligand-gated channels of the nicotinic and glutamate superfamilies (Barnard, 1996), native P2X receptors in cells also might form by the hetero-oligomerization of different subunits. The first kind of evidence is that the same cells often express more than one subunit mRNA. For example, throughout the nervous system and in some epithelial cells, the mRNAs for the P2X4 and P2X6 subunits have a widely overlapping distribution (Collo et al., 1996). A second finding that may suggest heteromultimeric channels is that the properties of the currents evoked by ATP in native cells do not always correspond to those observed when subunits are expressed singly in heterologous systems. One example is that rat P2X4 and P2X6 receptors are relatively insensitive to the commonly used P2X receptor antagonists suramin and pyridoxal 5-phosphate-6-azophenyl-2',4'-disulphonic acid (PPADS), although responses to ATP recorded from central neurons that express this combination are blocked readily by these antagonists.

The further example in which the properties of native cells do not correspond well to those of any subunit expressed alone comes from sensory neurons. Many primary afferent neurons, including nodose ganglion cells (Khakh et al., 1995; Lewis et al., 1995) as well as some identified trigeminal ganglion nociceptors (Cook et al., 1997), respond both to ATP and its analog alpha beta methylene-ATP (alpha beta meATP) with an inward current that desensitizes only minimally during a few seconds (see Surprenant et al., 1995). In contrast, in cells expressing cloned P2X receptors, alpha beta meATP either elicits strongly desensitizing currents (P2X1 or P2X3) or has no effect (P2X2, P2X4, P2X5, and P2X6). The nondesensitizing response to alpha beta meATP observed in the sensory neurons can be reproduced in HEK 293 cells by coexpression of P2X2 and P2X3 receptor cDNAs; because this phenotype could not be accounted for readily by any simple mixing of channels with P2X2 and P2X3 properties, it was concluded that heteromeric channels must be formed (Lewis et al., 1995).

The main aim of the present experiments was to determine directly whether P2X2 and P2X3 receptor subunits could form a stable heteromeric complex. This was done by expressing the two cDNAs with distinct C-terminal epitope tags that could be used for immunoprecipitation and detection. Baculovirus was used as the vector, and membrane expression of the channels after infection of insect cells was shown by radioligand binding and whole-cell patch-clamp recording.


MATERIALS AND METHODS

Baculovirus construction and amplification. P2X2 and P2X3 receptor coding regions were each fused at the C terminal via linker DPGLN to either of two epitope tags [EE tag: EYMPME, Grussenmeyer et al. (1985); 179 tag: CLEPYTACD, Whitehorn et al. (1995)]. The resulting four cDNAs were cloned into pFastBac1 and transformed into DH10Bac-competent cells (Life Technologies, Grand Island, NY). Recombinant baculovirus subsequently was generated by homologous recombination via transfection of 1 × 106 insect cells with 5 µg of each mini-prep recombinant bacmid DNA in the presence of 10 µg of Cellfectin (Life Technologies) in 35 mm tissue culture plates (Nunc, Roskilde, Denmark). Virus was harvested after 72 hr incubation at 27°C and amplified at a multiplicity of infection of 0.1 pfu/cell in suspension culture until virus titers approximating 108 pfu/ml were obtained. Large-scale virus stocks were harvested after 1 week by centrifugation at 1000 × g for 45 min, and supernatants were stored at 4°C. Virus titers were estimated by plaque assay (Knudson and Tinsley, 1974) and confirmed by 3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl-tetrazolium bromide (MTT) endpoint assay. For this assay, serial dilutions of virus (10-5 to 10-10) were made directly into insect cells suspensions (8 × 105 cells/ml). Multiple repeats of 100 µl aliquots were incubated at 27°C for 72 hr. MTT (20 µl of 7.5 mg/ml) was added to each well, and the cleavage of tetrazolium salt to formazan by noninfected proliferating cells allowed spectrophotometric detection of the viral endpoint. Virus titer and associated error were calculated from the endpoint, as described by Nielsen et al. (1992).

Cell culture and infection. Spodoptera frugiperda (sf9) insect cells (CRL-1711, American Type Culture Collection, Rockville, MD) were maintained in SF900II serum-free medium (Life Technologies) as 100 ml suspension cultures in 250 ml Erlenmeyer flasks (Schott, Mainz, Germany) and shaken at 150 rpm on an orbital shaker at 27°C. Cultures were grown until 2-3 × 106 cell/ml and subcultured at 3 × 105 cell/ml. Cell density was determined with a hemocytometer; viability was assessed by exclusion of 0.2% trypan blue (Sigma, St. Louis, MO). Reported cell viability estimations represent the mean of triplicate estimations ± 95% confidence interval calculated from variances estimated via the method by Nielsen et al. (1991).

For infections, cultures were pooled at 1.5 × 106 cell/ml, centrifuged at 1000 × g for 5 min, and resuspended in fresh medium. Resuspended cultures were inoculated at a multiplicity of 5 pfu/cell with baculovirus encoding PX2179, P2X3EE, or P2X2179 and P2X3EE. A further uninfected culture was used as a control. Cultures were shaken at 200 rpm at 27°C for 80 hr, and aliquots were removed at 0, 23, 39, 52, and 80 hr; these were were stored at -80°C.

Immunoprecipitation and Western blotting. Cells (2 × 107) were lysed on ice in 2 ml of Tris-buffered saline [TBS; (in mM): 20 Tris, 150 NaCl, 1 CaCl2, and 1 MgCl2) with 1% Triton X-100 and homogenized (Polytron; twice for 10 sec). Lysate was centrifuged at 12,000 × g for 10 min at 4°C, and the supernatant was transferred to 200 µl of a 1:1 mixture of washed protein A-agarose/protein G-agarose (Pharmacia, Uppsala, Sweden) for preadsorption of background proteins. Samples were rotated for 1 hr at 4°C, and beads were pelleted at 12,000 × g for 3 min. Supernatant (800 µl) was rotated at 1 hr at 4°C with either anti-EE or anti-179 antibodies (25 µg/ml final concentration) and rotated overnight after the addition of 100 µl of washed protein A-agarose/protein G. Beads were washed three times in lysis buffer by repeated centrifugation (12,000 × g for 3 min) and rotation (4°C for 10 min). Each pellet was resuspended in 50 µl of sample buffer and boiled for 5 min; after 1 min of centrifugation 10 µl was run on 12% Tris-glycine gels (Novex, San Diego, CA). Samples immunoprecipitated with anti-EE or anti-179 antibody were detected by Western blot/ECL format (Amersham, Braunschweig, Germany), using the anti-179 or anti-EE antibody, respectively, as the primary antibody and anti-mouse IgG as the secondary antibody. In some experiments lysates of cells expressing P2X2 receptors were treated with Endo H (Boehringer Mannheim, Mannheim, Germany) (50 mU/ml, overnight at 4°C).

[35S]ATPgamma S binding. The ligand binding assay was similar to that described by Michel et al. (1996a,b), modified by the use of multiscreen membrane plates (0.65 µm pore size; Millipore, Bedford, MA) to separate bound from unbound radioligand. Intact insect cells infected with P2X2 or P2X3 receptor baculovirus (5 × 104/well) were incubated for 2-3 hr at 4°C with [35S]ATPgamma S in 50 mM Tris-HCl, pH 7.1, plus 1 mM EDTA. This buffer, with 2 µg/ml aprotinin, 2 µg/ml leupeptin, 100 µg/ml phenylmethylsulfonyl fluoride, and 50 µg/ml Nalpha -tosyl-Lys chloromethyl ketone, also was used for sample and reagent dilution and plate washing. Unbound radioligand was washed from plates by vacuum filtration (3 × 250 µl/well), and plates were counted in a Wallac scintillator after the addition of 30 µl of scintillation fluid. For time course measurements, a single concentration of [35S]ATPgamma S was used, which was close to the KD (0.4 nM), and binding was measured at 23, 39, 52, and 80 hr postinfection. Nonspecific binding was defined by using 15 µM 2-methylthio-ATP; the total binding of [35S]ATPgamma S observed in the presence of 15 µM 2-methylthio-ATP was the same for infected and noninfected cells.

Electrophysiology. At ~30 or 52 hr after infection, cells were transferred from the culture to coverslips and allowed to attach for 1-2 hr at 27°C. Whole-cell recordings were obtained with glass pipettes (4-6 MOmega ) containing (in mM): 140 CsCl, 11 EGTA, and 10 HEPES. The external solution contained (in mM): 147 NaCl, 2 KCl, 2 CaCl2, 1 MgCl2, 12 glucose, and 10 HEPES. Agonists were applied by U-tube delivery system (Evans et al., 1995). Responses were obtained by applying agonist for 1 sec at intervals of 2 min (P2X2; P2X2 and P2X3) and 4 min (P2X3).


RESULTS

Time course of P2X receptor protein expression

P2X receptor subunit expression was monitored by antibody-specific protein production (Fig. 1). This was detectable but very weak at 23 hr after infection and much stronger at 39 and 52 hr. Both the P2X2 and the P2X3 receptors migrated as several closely spaced bands, with molecular weights of ~64 and 50 kDa, respectively (Fig. 1). We assume that these represent differently glycosylated forms: treatment of the P2X2 receptor-infected cells with Endo H eliminated the higher molecular weight bands (data not shown). For both subtypes, some antibody-positive material disappeared between 52 and 80 hr after infection; bands at lower molecular weight that might result from degradation were not detected in either case. In cultures expressing the P2X2 receptor, the fraction of cells excluding trypan blue, a measure of cell lysis, fell from 97.5 ± 9.5% at time 0, to 93.5 ± 9.7% at 23 hr, 83.5 ± 7.9% at 39 hr, 52.5 ± 5.4% at 52 hr, and 6 ± 0.9% at 80 hr (n = 6). The P2X receptor expression and lysis kinetics for the P2X3 receptor-infected and coinfected cultures were not significantly different from those observed with P2X2 alone.
Fig. 1. Time course of P2X receptor expression by sf9 cells infected with baculovirus. Immunoblots detected epitope-tagged P2X2 (anti-179; top) and P2X3 (anti-EE; bottom) receptors at four times (23, 39, 52, and 80 hr) after infection.
[View Larger Version of this Image (70K GIF file)]

Binding of [35S]ATPgamma S

The specific binding of [35S]ATPgamma S to cells infected with P2X2 receptor constructs was well fit by a simple adsorption isotherm when it was measured 48 hr after infection (Fig. 2). From the direct fit of a hyperbola to the data, the KD was 0.6 nM, and the Bmax corresponded to 3 × 106 binding sites per cell. Saturation analysis also was performed for cells expressing P2X3, and both receptors and the KD estimates were not significantly different (P2X2, 0.63 ± 0.08 nM; P2X3, 0.54 ± 0.06 nM; P2X2 and P2X3, 0.57 ± 0.09 nM; n = 3). These values are similar to those described for P2X2 and P2X3 expressed in other systems (Michel et al., 1996a,b; Miller et al., 1996); in subsequent experiments a single concentration of [35S]ATPgamma S was used (0.4 nM) with or without 15 µM 2MeSATP. For P2X2 receptors, the number of specific binding sites was 3.4 ± 0.8 × 106/cell at 52 hr and 1.2 ± 0.3 × 106/cell at 80 hr; the corresponding values for cells infected with P2X3 receptors were 6.6 ± 1.6 × 105/cell at 52 hr and 3.7 ± 2.1 × 105/cell at 80 hr; for cells infected with P2X2 and P2X3 receptors, they were 1.3 ± 0.2 × 106/cell at 52 hr and 5.8 ± 1.0 × 105/cell at 80 hr (n = 3 in each case). The decline between 52 and 80 hr correlates well with the results of immunoblotting (Fig. 1).
Fig. 2. Binding of [35S]ATPgamma S to sf9 cells infected at 48 hr (A) or at different times (B) after infection with baculovirus encoding the P2X2 receptor. A, The points for specific binding are fit to Bmax [L]n/([L]n + KDn), where [L] is the free [35S]ATPgamma S concentration; they provide estimates for Bmax of 2.8 × 106 binding sites per cell and KD of 0.63 nM. The points are the means of triplicates from two experiments, and error bars indicate 95% confidence limits from Student's t distribution. B, The number of binding sites per cell was greater for P2X2 than for P2X3 or P2X2 plus P2X3. In each case this was maximal at 52 hr.
[View Larger Version of this Image (19K GIF file)]

ATP-induced currents in infected sf9 cells

ATP (30 µM) applied for 1-2 sec evoked a sustained current in cells infected with P2X2 receptors, whereas alpha beta meATP (30 µM) had no effect (n = 2; Fig. 3). The current evoked by ATP (30 µM) was 4.5 ± 0.6 nA (n = 6) at 30 hr after infection, 1.3 ± 0.4 nA (n = 4) at 40 hr, and 1.5 ± 0.4 nA (n = 4) at 48 hr. In cells expressing P2X3 receptors, alpha beta meATP (30 µM) evoked a rapidly desensitizing current in four of five cells tested (1.5 ± 0.3 nA, n = 4; 50 hr after infection; Fig. 3). However, this was seen only after pretreatment of cells with apyrase (30 U/ml for 2 hr); alpha beta meATP (30 µM) had no effect in five other cells infected with P2X3 receptor baculovirus, which were not treated with apyrase. This result is similar to that observed for HL60 cells (which express P2X1 receptors), in which chronic desensitization by ATP released from the cells prevents any current being elicited by ATP unless apyrase is applied first (Buell et al., 1996). Cells infected with both the P2X2 and P2X3 baculovirus responded to ATP (30 µM; 4.7 ± 2.7 nA; n = 2) and alpha beta meATP (30 µM; 5.9 ± 2.9 nA; n = 2) with a sustained current (Fig. 3; tested 30 hr after infection); this was similar to that previously observed for HEK cells transfected with both receptor cDNAs (Lewis et al., 1995).
Fig. 3. Membrane currents evoked by ATP and alpha beta meATP recorded in sf9 cells infected with baculovirus encoding P2X2, P2X3, or P2X2 and P2X3 receptors. Solid lines above traces indicate period of application of agonist. Top, Cells expressing P2X2 receptors responded to ATP (30 µM), but not to alpha beta meATP (30 µM); the current showed little desensitization. All three traces were taken in order from the same cell; the second application of ATP was 8 min after the first. Recordings were made 30 hr after infection. Middle, Cells expressing P2X3 receptors responded both to ATP (30 µM) and to alpha beta meATP (30 µM); the current desensitized almost fully within the period of application (1 sec). Recordings were made 50 hr after infection and 2 hr after adding apyrase (30 U/ml). Bottom, Cells coinfected with baculovirus encoding P2X2 and P2X3 receptors responded both to ATP (30 µM) and to alpha beta meATP (30 µM), but in this case the current desensitized much more slowly. Recordings were made 50 hr after infection.
[View Larger Version of this Image (16K GIF file)]

Coimmunoprecipitation of P2X2 and P2X3 subunits

Insect cells infected with P2X2179, P2X3EE, or both receptors were harvested after 52 hr and solubilized with Triton X-100; then the supernatant was immunoprecipitated with anti-179 or anti-EE antibodies. P2X2179 receptors could be immunoprecipitated with anti-179, but not with anti-EE (Fig. 4, lanes 1 and 2). P2X3EE receptors could be immunoprecipitated with anti-EE, but not with anti-179 (Fig. 4, lanes 5 and 6). In cells coinfected with both P2X2179 and P2X3EE, the material immunoprecipitated by anti-179 or anti-EE could be detected with either anti-179 (Fig. 4, lanes 3 and 4) or anti-EE (Fig. 4, lanes 7 and 8). In each case the immunoprecipitated material corresponded in size to the cognate receptor; P2X2179 ran as a broad smear of ~64 kDa, and P2X3EE ran as a series of bands, of which the smallest was ~50 kDa (Fig. 4).
Fig. 4. Coimmunoprecipitation of P2X2 and P2X3 subunits. Cells were infected with baculovirus encoding epitope-tagged P2X2 receptors (P2X2179), P2X3 receptors (P2X3EE), or both receptors. Cells were harvested at 52 hr and solubilized with 1% Triton X-100; the supernatant was immunoprecipitated with either antibody, as indicated. Then either antibody was used to identify the proteins in the immunoprecipitate. The antibody heavy chain lies within the P2X3 bands.
[View Larger Version of this Image (44K GIF file)]


DISCUSSION

The main result of the present work is that P2X2 and P2X3 receptors express robustly in sf9 cells infected with baculovirus constructs, which encode them, and that they can be coimmunoprecipitated. Receptor expression was determined in three ways. Epitope tags presumably would detect individual subunits whether or not in the plasma membrane. Binding of [35S]ATPgamma S would detect subunits or, presumably, multimeric forms in the plasma membrane; however, at later times postinfection this would include intracellular membranes from cells undergoing lysis. Electrophysiological recording detects functioning multimeric receptors in the membrane of intact cells.

The time course of appearance of P2X receptor protein was consistent with what is known about the progress of infection of baculovirus in insect cells (O'Reilly et al., 1994). Minimal protein was detectable at 23 hr, but there was strong expression at 39 hr. By the time of maximal expression (52 hr), whether measured by epitope tags or by ligand binding, >40% of the cells were permeable to trypan blue. There were no obvious differences in these kinetics between P2X2 and P2X3 receptors. However, there was three- to fourfold less protein expressed by the P2X3-infected cells than the P2X2-infected cells. Coinfection with P2X2 and P2X3 baculovirus also resulted in fewer [35S]ATPgamma S binding sites per cell than expression of P2X2 receptors alone. These differences were also qualitatively apparent in the immunoblots (see Fig. 1).

The binding sites for [35S]ATPgamma S on baculovirus-infected sf9 cells have the same KD (~0.5 nM) as those reported in more complete studies by Michel et al. (1996a,b) for P2X2 receptors expressed by Semliki forest virus in Chinese hamster ovary cells. We observed maximal expression of ~3.3 × 106 binding sites per cell; this corresponds to ~50 pmol/mg protein (assuming that one cell has 1.1 × 10-7 mg of protein), which is approximately twofold larger than the values reported for Semliki forest virus infection by Michel et al. (1996a). [35S]ATPgamma S also has been used previously to label P2X1 receptors (Michel et al., 1996b) and P2X3 receptors (Miller et al., 1996) expressed by Semliki forest virus. The relatively high levels of expression and the ability to follow the receptor by ligand binding may be useful in efforts to purify significant amounts of protein.

The electrophysiological studies on infected insect cells were more difficult on cultures 50 hr after infection because cells were poorly adherent and fragile to gigaseal formation. However, satisfactory recordings were readily made 30 hr after infection, and large (up to 9 nA) ATP-induced currents were observed. With respect to desensitization of the current during the application and also with respect to the relative effects of ATP and alpha beta meATP, these currents closely resembled those observed from other cells infected (Semliki forest virus) or transfected with P2X2 and P2X3 receptors (Evans et al., 1995, 1996). Most strikingly, cells infected with both P2X2 and P2X3 receptor baculovirus showed the phenotype of a slowly desensitizing response to alpha beta meATP, which is not readily accounted for by the independent expression of the two subunits (Lewis et al., 1995).

These electrophysiological results and the more extensive previous work (Lewis et al., 1995) strongly suggest that P2X2 and P2X3 subunits can form a new phenotype by heteropolymerization. The immunoprecipitation now demonstrates this directly and shows that the association in the membrane between P2X2 and P2X3 receptor subunits is sufficiently strong to withstand solubilization with 1% Triton X-100. The method now can be extended to the other members of the P2X receptor family in an effort to determine which subunits can copolymerize when heterologously expressed. Such a direct approach will be particularly useful because many of the possible combinations are not expected to provide any unique phenotype, given the fact that their properties are similar when expressed as single subunits (Collo et al., 1996). On the other hand, they do not address the as yet unsolved question of the actual receptor stoichiometry. Similar experiments on native cells and tissues, using coimmunoprecipitation with antibodies raised against the naturally occurring receptors (Vulchanova et al., 1996; Cook et al., 1997), also will be important in view of the recent evidence that specific combinations may underlie the responses of neurons in defined functional pathways (Cook et al., 1997).


FOOTNOTES

Received April 18, 1996; revised June 9, 1997; accepted June 11, 1997.

  

We thank Dr. Anton Michel for his advice in establishing the [35S]ATPgamma S binding assay.

Correspondence should be addressed to Dr. K. M. Radford, Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development, Plan-les-Ouates, 1228 Geneva, Switzerland.



REFERENCES

  • Barnard EA (1996) The transmitter-gated channels: a range of receptor types and structures. Trends Pharmacol Sci 17:305-309[Medline].
  • Buell G, Michel AD, Lewis C, Collo G, Humphrey PPA, Surprenant A (1996) P2X1 receptor activation in HL60 cells. Blood 87:2659-2664[Abstract/Free Full Text].
  • Collo G, North RA, Kawashima E, Merlo-Pich E, Neidhart S, Surprenant A, Buell G (1996) Cloning of P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. J Neurosci 16:2495-2507[Abstract/Free Full Text].
  • Cook SP, Vulchanova L, Hargreaves KM, Elde RP, McCleskey EW (1997) Distinct P2X receptors mediate ATP actions on nociceptive and non-nociceptive neurons. Nature 387:505-508[Medline].
  • Evans RJ, Lewis C, Buell G, North RA, Surprenant A (1995) Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2X purinoceptors). Mol Pharmacol 48:178-183[Abstract].
  • Evans RJ, Lewis C, Virginio C, Lundstrom K, Buell G, Surprenant A, North RA (1996) Ionic permeability of, and divalent cation effects on, two ATP-gated cation channels (P2X receptors) expressed in mammalian cells. J Physiol (Lond) 497:413-422[ISI][Medline].
  • Grussenmeyer T, Scheidtmann KH, Hutchinson MA, Eckhart W, Walter G (1985) Complexes of polyoma virus medium T antigen and cellular proteins. Proc Natl Acad Sci USA 82:7952-7954[Abstract/Free Full Text].
  • Khakh BS, Humphrey PPA, Surprenant A (1995) Electrophysiological properties of P2X purinoceptors in rat superior cervical, nodose, and guinea pig coeliac neurons. J Physiol (Lond) 484:385-395[ISI][Medline].
  • Knudson DL, Tinsley TW (1974) Replication of a nuclear polyhedrosis virus in a continuous cell culture of Spodoptera frugiperda: purification, assay of infectivity, and growth characteristics of the virus. J Virol 14:934-944[Abstract/Free Full Text].
  • Lewis C, Neidhart S, Holy C, North RA, Buell G, Surprenant A (1995) Coexpression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons. Nature 377:432-435[Medline].
  • Michel AD, Lundstrom K, Buell GN, Surprenant A, Valera S, Humphrey PPA (1996a) A comparison of the binding characteristics of recombinant P2X1 and P2X2 purinoceptors. Br J Pharmacol 118:1806-1812[ISI][Medline].
  • Michel AD, Lundstrom K, Buell GN, Surprenant A, Valera S, Humphrey PPA (1996b) The binding characteristics of a human bladder recombinant P2X purinoceptor, labelled with [3H]alpha beta meATP, [35S]ATPgamma S, or [33P]-ATP. Br J Pharmacol 117:1254-1260[ISI][Medline].
  • Miller KJ, Michel AD, Buell G, Lundstrom K, Humphrey PPA (1996) Direct labelling of P2X3 and P2X4 purinoreceptors using [35S]ATPgamma S. Br J Pharmacol 118:18P.
  • Nielsen LK, Smyth GK, Greenfield PF (1991) Hemocytometer cell count distributions: implications of non-Poisson behaviour. Biotechnol Prog 7:560-563.
  • Nielsen LK, Smyth GK, Greenfield PF (1992) Accuracy of the endpoint assay for virus titration. Cytotechnology 8:231-236[ISI][Medline].
  • North RA (1996) Families of ion channels with two hydrophobic segments. Curr Opin Cell Biol 8:474-483[ISI][Medline].
  • O'Reilly DR, Miller LK, Luckow VA (1994) An overview of baculoviruses. In: Baculovirus expression vectors: a laboratory manual (O'Reilly DR, Miller LK, Luckow VA, eds), pp 8-10. New York: Freeman.
  • Surprenant A, Buell G, North RA (1995) P2X receptors bring new structure to ligand-gated ion channels. Trends Neurosci 18:224-229[ISI][Medline].
  • Vulchanova L, Arvidsson U, Riedl M, Wang J, Buell G, Surprenant A, North RA, Elde RP (1996) Differential distribution of two ATP-gated ion channels (P2X receptors) determined by immunocytochemistry. Proc Natl Acad Sci USA 93:8063-8067[Abstract/Free Full Text].
  • Whitehorn EA, Tate E, Yanofsky SD, Kochersperger L, Davis A, Mortensen RB, Yonkovich S, Bell K, Dower WJ, Barrett RW (1995) A generic method for expression and use of "tagged" soluble versions of cell surface receptors. Biotechnology 13:1215-1219[Medline].

Copyright ©1997 Society for Neuroscience   0270-6474/1997/176529-05$05.00/0



This article has been cited by other articles:


Home page
Physiol. Rev.Home page
G. Burnstock
Physiology and Pathophysiology of Purinergic Neurotransmission
Physiol Rev, April 1, 2007; 87(2): 659 - 797.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
V. A. Campanucci, M. Zhang, C. Vollmer, and C. A. Nurse
Expression of Multiple P2X Receptors by Glossopharyngeal Neurons Projecting to Rat Carotid Body O2-Chemoreceptors: Role in Nitric Oxide-Mediated Efferent Inhibition.
J. Neurosci., September 13, 2006; 26(37): 9482 - 9493.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Chaumont, L.-H. Jiang, A. Penna, R. A. North, and F. Rassendren
Identification of a Trafficking Motif Involved in the Stabilization and Polarization of P2X Receptors
J. Biol. Chem., July 9, 2004; 279(28): 29628 - 29638.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L.-H. Jiang, M. Kim, V. Spelta, X. Bo, A. Surprenant, and R. A. North
Subunit Arrangement in P2X Receptors
J. Neurosci., October 1, 2003; 23(26): 8903 - 8910.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
K. Tsuzuki, A. Ase, P. Seguela, T. Nakatsuka, C.-Y. Wang, J.-X. She, and J. G. Gu
TNP-ATP-Resistant P2X Ionic Current on the Central Terminals and Somata of Rat Primary Sensory Neurons
J Neurophysiol, June 1, 2003; 89(6): 3235 - 3242.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-L. He, H. Zemkova, and S. S. Stojilkovic
Dependence of Purinergic P2X Receptor Activity on Ectodomain Structure
J. Biol. Chem., March 14, 2003; 278(12): 10182 - 10188.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T.-a. Koshimizu, S. Ueno, A. Tanoue, N. Yanagihara, S. S. Stojilkovic, and G. Tsujimoto
Heteromultimerization Modulates P2X Receptor Functions through Participating Extracellular and C-terminal Subdomains
J. Biol. Chem., November 27, 2002; 277(49): 46891 - 46899.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M.-L. He, T.-a. Koshimizu, M. Tomic', and S. S. Stojilkovic
Purinergic P2X2 Receptor Desensitization Depends on Coupling between Ectodomain and C-Terminal Domain
Mol. Pharmacol., November 1, 2002; 62(5): 1187 - 1197.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. A. North
Molecular Physiology of P2X Receptors
Physiol Rev, October 1, 2002; 82(4): 1013 - 1067.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. G. Brown, A. Townsend-Nicholson, K. A. Jacobson, G. Burnstock, and B. F. King
Heteromultimeric P2X1/2 Receptors Show a Novel Sensitivity to Extracellular pH
J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 673 - 680.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. H. Lee, T. Chiba, and D. C. Marcus
P2X2 Receptor Mediates Stimulation of Parasensory Cation Absorption by Cochlear Outer Sulcus Cells and Vestibular Transitional Cells
J. Neurosci., December 1, 2001; 21(23): 9168 - 9174.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
B. A. Chizh and P. Illes
P2X Receptors and Nociception
Pharmacol. Rev., December 1, 2001; 53(4): 553 - 568.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. Vassort
Adenosine 5'-Triphosphate: a P2-Purinergic Agonist in the Myocardium
Physiol Rev, April 1, 2001; 81(2): 767 - 806.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
B. S. Khakh, G. Burnstock, C. Kennedy, B. F. King, R. A. North, P. Seguela, M. Voigt, and P. P. A. Humphrey
International Union of Pharmacology. XXIV. Current Status of the Nomenclature and Properties of P2X Receptors and Their Subunits
Pharmacol. Rev., March 1, 2001; 53(1): 107 - 118.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T.-a. Koshimizu, M. Tomic, A. O.-L. Wong, D. Zivadinovic, and S. S. Stojilkovic
Characterization of Purinergic Receptors and Receptor-Channels Expressed in Anterior Pituitary Cells
Endocrinology, November 1, 2000; 141(11): 4091 - 4099.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. F. King, A. Townsend-Nicholson, S. S. Wildman, T. Thomas, K. M. Spyer, and G. Burnstock
Coexpression of Rat P2X2 and P2X6 Subunits in Xenopus Oocytes
J. Neurosci., July 1, 2000; 20(13): 4871 - 4877.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T.-a. Koshimizu, M. Koshimizu, and S. S. Stojilkovic
Contributions of the C-terminal Domain to the Control of P2X Receptor Desensitization
J. Biol. Chem., December 31, 1999; 274(53): 37651 - 37657.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. Stoop, S. Thomas, F. Rassendren, E. Kawashima, G. Buell, A. Surprenant, and R. A. North
Contribution of Individual Subunits to the Multimeric P2X2 Receptor: Estimates based on Methanethiosulfonate Block at T336C
Mol. Pharmacol., November 1, 1999; 56(5): 973 - 981.
[Abstract] [Full Text]


Home page
J. Neurophysiol.Home page
E. C. Burgard, W. Niforatos, T. van Biesen, K. J. Lynch, E. Touma, R. E. Metzger, E. A. Kowaluk, and M. F. Jarvis
P2X Receptor-Mediated Ionic Currents in Dorsal Root Ganglion Neurons
J Neurophysiol, September 1, 1999; 82(3): 1590 - 1598.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. E. Torres, T. M. Egan, and M. M. Voigt
Identification of a Domain Involved in ATP-gated Ionotropic Receptor Subunit Assembly
J. Biol. Chem., August 6, 1999; 274(32): 22359 - 22365.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K.-T. Le, E. Boue-Grabot, V. Archambault, and P. Seguela
Functional and Biochemical Evidence for Heteromeric ATP-gated Channels Composed of P2X1 and P2X5 Subunits
J. Biol. Chem., May 28, 1999; 274(22): 15415 - 15419.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. E. Torres, T. M. Egan, and M. M. Voigt
Hetero-oligomeric Assembly of P2X Receptor Subunits. SPECIFICITIES EXIST WITH REGARD TO POSSIBLE PARTNERS
J. Biol. Chem., March 5, 1999; 274(10): 6653 - 6659.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
L. Naemsch, A. Weidema, S. Sims, T. Underhill, and S. Dixon
P2X(4) purinoceptors mediate an ATP-activated, non-selective cation current in rabbit osteoclasts
J. Cell Sci., January 12, 1999; 112(23): 4425 - 4435.
[Abstract] [PDF]


Home page
BloodHome page
G. Buell, I.P. Chessell, A.D. Michel, G. Collo, M. Salazzo, S. Herren, D. Gretener, C. Grahames, R. Kaur, M.H. Kosco-Vilbois, et al.
Blockade of Human P2X7 Receptor Function With a Monoclonal Antibody
Blood, November 15, 1998; 92(10): 3521 - 3528.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K.-T. Le, K. Babinski, and P. Seguela
Central P2X4 and P2X6 Channel Subunits Coassemble into a Novel Heteromeric ATP Receptor
J. Neurosci., September 15, 1998; 18(18): 7152 - 7159.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
V. Ralevic and G. Burnstock
Receptors for Purines and Pyrimidines
Pharmacol. Rev., September 1, 1998; 50(3): 413 - 492.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Newbolt, R. Stoop, C. Virginio, A. Surprenant, R. A. North, G. Buell, and F. Rassendren
Membrane Topology of an ATP-gated Ion Channel (P2X Receptor)
J. Biol. Chem., June 12, 1998; 273(24): 15177 - 15182.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T.-a. Koshimizu, M. Tomic, M. Koshimizu, and S. S. Stojilkovic
Identification of Amino Acid Residues Contributing to Desensitization of the P2X2 Receptor Channel
J. Biol. Chem., May 22, 1998; 273(21): 12853 - 12857.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow